Toon Laeremans

Toon Laeremans, ir., Ph.D., has more than 15 years of experience in single domain antibody discovery against a wide array of target classes including multi-transmembrane spanning proteins such as GPCRs and ion channels and is inventor on multiple patent families covering both technology and compounds.

Between 1998 and 2002, he performed postdoctoral research on camelid antibodies in the group of Professor Serge Muyldermans (VIB-Vrije Universiteit Brussel). In 2002, Toon joined Ablynx as one of the very first employees. From start-up to 2010, he was involved in internal and collaborative antibody discovery programs, several of which are currently in clinical trials. Between 2007 and 2010 he was team leader antibody discovery.

In 2010, he moved to the Steyaert lab to develop the CONFO® technology platform and spinning out Confo Therapeutics.

Toon Laeremans is the Founder & Head of Technology at Confo Therapeutics, based in Europe. With a background in Biotechnology, Toon Laeremans has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.